Phase I/II trial of recombinant interleukin-2 [aldesleukin] in symptomatic human immunodeficiency virus-infected children
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Aldesleukin (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 21 May 2012 Biomarkers information updated
- 19 Oct 2005 New trial record.